Medpace Holdings Inc (MEDP)

Gross profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Gross profit (ttm) US$ in thousands 474,178 433,997 405,803 378,142 374,854 383,504 384,845 365,425 326,486 287,814 253,005 234,461 217,399 214,615 206,259 192,662 179,208 182,871 165,511 169,950
Revenue (ttm) US$ in thousands 2,108,554 2,068,966 2,028,148 1,960,912 1,899,742 1,816,339 1,717,384 1,607,723 1,488,796 1,387,029 1,289,052 1,216,138 1,145,156 1,094,017 1,028,823 955,525 926,439 896,133 881,998 891,107
Gross profit margin 22.49% 20.98% 20.01% 19.28% 19.73% 21.11% 22.41% 22.73% 21.93% 20.75% 19.63% 19.28% 18.98% 19.62% 20.05% 20.16% 19.34% 20.41% 18.77% 19.07%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $474,178K ÷ $2,108,554K
= 22.49%

Medpace Holdings Inc's gross profit margin has shown fluctuation over the analyzed period from March 31, 2020, to December 31, 2024. The gross profit margin stood at 19.07% on March 31, 2020, and experienced variations, reaching its lowest point of 18.77% on June 30, 2020. Subsequently, the gross profit margin improved to 20.41% on September 30, 2020, before dropping to 19.34% by December 31, 2020.

From March 31, 2021, the gross profit margin displayed a general upward trend, with fluctuations along the way. Notably, the margin increased to 22.73% by March 31, 2023, marking its highest point during the period analyzed. However, the margin declined to 19.73% by December 31, 2023.

The performance of the gross profit margin continued to fluctuate through June 30, 2024, showing improvements and declines. The margin reached 22.49% by December 31, 2024, indicating an overall increase compared to the initial periods analyzed.

Overall, Medpace Holdings Inc's gross profit margin has displayed variability over the years, with periods of both improvement and decline. It is essential for the company to continue monitoring and managing its cost of goods sold and revenue generation to ensure the sustainability and profitability of its operations.